759 related articles for article (PubMed ID: 14576433)
1. The BRCT domain is a phospho-protein binding domain.
Yu X; Chini CC; He M; Mer G; Chen J
Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
[TBL] [Abstract][Full Text] [Related]
2. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
Manke IA; Lowery DM; Nguyen A; Yaffe MB
Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
[TBL] [Abstract][Full Text] [Related]
3. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
[TBL] [Abstract][Full Text] [Related]
4. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
5. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
Rodriguez M; Yu X; Chen J; Songyang Z
J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
[TBL] [Abstract][Full Text] [Related]
6. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA.
Yamane K; Tsuruo T
Oncogene; 1999 Sep; 18(37):5194-203. PubMed ID: 10498869
[TBL] [Abstract][Full Text] [Related]
7. Cell signaling. The BRCT domain: signaling with friends?
Caldecott KW
Science; 2003 Oct; 302(5645):579-80. PubMed ID: 14576410
[No Abstract] [Full Text] [Related]
8. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
Bork P; Hofmann K; Bucher P; Neuwald AF; Altschul SF; Koonin EV
FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
[TBL] [Abstract][Full Text] [Related]
9. TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.
Wright RH; Dornan ES; Donaldson MM; Morgan IM
Biochem J; 2006 Dec; 400(3):573-82. PubMed ID: 16984230
[TBL] [Abstract][Full Text] [Related]
10. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
Venere M; Snyder A; Zgheib O; Halazonetis TD
Cancer Res; 2007 Jul; 67(13):6100-5. PubMed ID: 17616665
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
Botuyan MV; Nominé Y; Yu X; Juranic N; Macura S; Chen J; Mer G
Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
[TBL] [Abstract][Full Text] [Related]
13. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
15. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
[TBL] [Abstract][Full Text] [Related]
16. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
[TBL] [Abstract][Full Text] [Related]
17. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
Au WW; Henderson BR
Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Williams RS; Lee MS; Hau DD; Glover JN
Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.
Yamane K; Katayama E; Sugasawa K; Tsuruo T
Oncogene; 2000 Apr; 19(16):1982-91. PubMed ID: 10803459
[TBL] [Abstract][Full Text] [Related]
20. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
